相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent Clostridioides difficile infection in the Japanese setting: a case control study
Takumi Umemura et al.
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Methodological quality and synthesis of case series and case reports
Mohammad Hassan Murad et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial
Susy S. Hota et al.
CLINICAL INFECTIOUS DISEASES (2017)
An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy
E. Bouza et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
OUTCOMES IN PATIENTS WITH RECURRENT CLOSTRIDIUM DIFFICILE INFECTION TREATED WITH VANCOMYCIN TAPER
Anne M. Meehan et al.
GASTROENTEROLOGY (2017)
A Propensity-Matched Analysis Between Standard Versus Tapered Oral Vancomycin Courses for the Management of Recurrent Clostridium difficile Infection
Chris A. Gentry et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States A Cohort Study
Gene K. Ma et al.
ANNALS OF INTERNAL MEDICINE (2017)
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
G. Cammarota et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Differences of the Fecal Microflora With Clostridium difficile Therapies
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2015)
Meta-analysis in clinical trials revisited
Rebecca DerSimonian et al.
CONTEMPORARY CLINICAL TRIALS (2015)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Can we identify patients at high risk of recurrent Clostridium difficile infection?
C. P. Kelly
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals
Becky A. Miller et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Clostridium difficile infection in Europe: a hospital-based survey
Martijn P. Bauer et al.
LANCET (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
K. W. Garey et al.
JOURNAL OF HOSPITAL INFECTION (2008)
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027
Jacques Pepin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
分享论文
